New approaches to studying early brain development in Down syndrome.
Ana A Baburamani, Prachi A Patkee, Tomoki Arichi and 1 others
PMID 31102269WHAT IT FOUND
This review argues that brain development in Down syndrome deviates before birth, so therapies targeting cognition in older children may be too late.
It suggests using advanced fetal and neonatal MRI to find earlier treatment windows, rather than reporting new clinical results.
Key findings
01Structural brain differences, such as reduced neuron number and altered cortical folding, emerge during fetal life and the newborn period, not just in adulthood.
02Current clinical practice relies on physiotherapy, occupational therapy, and speech and language therapy to help developmental milestones, but there is no known effective pharmacological intervention.
03Advanced MRI techniques can now safely image fetal and neonatal brains without sedation, offering a way to track these early deviations longitudinally.
STILL TO COME
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
This is a narrative review of existing literature and mouse models, not a clinical trial or observational study. It reports no new patient outcomes or efficacy data. The discussion of therapeutic windows is theoretical, based on the timing of brain development in animal models and postmortem human tissue, rather than tested interventions in infants.
The easy way to misread this
Do not interpret the discussion of early brain changes or mouse model therapies as evidence that any specific treatment works in infants with Down syndrome. The paper reviews the potential for future research into early intervention windows; it does not report clinical results or recommend a change in current therapy protocols.